Protein profiling underscores immunological functions of uterine cervical mucus plug in human pregnancy

Journal of Proteomics

Volumn 74, Issue 6, 2011, Pages 817-828

  Lee, Deug Chan ^a   Hassan, Sonia S ^a,b   Romero, Roberto ^a,b   Tarca, Adi L ^a,c   Bhatti, Gaurav ^a   Gervasi, Maria Teresa ^d   Caruso, Joseph A ^e   Stemmer, Paul M ^e   Kim, Chong Jai ^a,b   Hansen, Lea Kirstine ^f   Becher, Naja ^f   Uldbjerg, Niels ^f  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Wayne State University   (United States)

^d UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^e WAYNE STATE UNIVERSITY   (United States)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

Cervical mucus plug; Pregnancy; Proteomics

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CD81 ANTIGEN; PLASMA PROTEIN;

ARTICLE; CHOLESTEROL ESTERIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOLOGICAL PARAMETERS; INFLAMMATION; LABOR; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX MUCUS; VAGINA DISCHARGE;

CERVIX MUCUS; FEMALE; HUMANS; LABOR, OBSTETRIC; MASS SPECTROMETRY; PARTURITION; PREGNANCY; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 79955480849     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.02.025     Document Type: Article

References (56)

1. Chantler E., Sharma R., Sharman D. Changes in cervical mucus that prevent penetration by spermatozoa. Symp Soc Exp Biol 1989, 43:325-336.
2. Van Kooij R.J., Roelofs H.J., Kathmann G.A., Kramer M.F. Human cervical mucus and its mucous glycoprotein during the menstrual cycle. Fertil Steril 1980, 34:226-233.
3. Wolf D.P., Sokoloski J.E., Litt M. Composition and functioin of human cervical mucus. Biochim Biophys Acta 1980, 630:545-558.
4. Becher N., Waldorf K.A., Hein M., Uldbjerg N. The cervical mucus plug: structured review of the literature. Acta Obstet Gynecol Scand 2009, 88:502-513.
5. Becher N., Hein M., Danielsen C.C., Uldbjerg N. Matrix metalloproteinases and their inhibitors in the cervical mucus plug at term of pregnancy. Am J Obstet Gynecol 2004, 191:1232-1239.
6. Hein M., Valore E.V., Helmig R.B., Uldbjerg N., Ganz T. Antimicrobial factors in the cervical mucus plug. Am J Obstet Gynecol 2002, 187:137-144.
7. Habte H.H., de Beer C., Lotz Z.E., Tyler M.G., Schoeman L., Kahn D., Mall A.S. The inhibition of the human immunodeficiency virus type 1 activity by crude and purified human pregnancy plug mucus and mucins in an inhibition assay. Virol J 2008, 5:59.
8. Yoon B.H., Romero R., Moon J.B., Shim S.S., Kim M., Kim G., Jun J.K. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001, 185:1130-1136.
9. Hassan S.S., Romero R., Tarca A.L., Nhan-Chang C.L., Mittal P., Vaisbuch E., Gonzalez J.M., Chaiworapongsa T., li-Fehmi R., Dong Z., Than N.G., Kim C.J. The molecular basis for sonographic cervical shortening at term: identification of differentially expressed genes and the epithelial-mesenchymal transition as a function of cervical length. Am J Obstet Gynecol 2010, 203:472.e1-472.e14.
10. Paidas M.J., Krikun G., Huang S.J., Jones R., Romano M., Annunziato J., Barnea E.R. A genomic and proteomic investigation of the impact of preimplantation factor on human decidual cells. Am J Obstet Gynecol 2010, 202:459.e1-459.e8.
11. Robinson J.M., Vandre D.D., Ackerman W.E. Placental proteomics: a shortcut to biological insight. Placenta 2009, S83-S89. Suppl A.
12. Walsh G.M., Rogalski J.C., Klockenbusch C., Kast J. Mass spectrometry-based proteomics in biomedical research: emerging technologies and future strategies. Expert Rev Mol Med 2010, 12:e30.
13. Pereira L., Reddy A.P., Alexander A.L., Lu X., Lapidus J.A., Gravett M.G., Nagalla S.R. Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor. Am J Obstet Gynecol 2010, 202:555.e1-555.e10.
14. Hitti J., Lapidus J.A., Lu X., Reddy A.P., Jacob T., Dasari S., Eschenbach D.A., Gravett M.G., Nagalla S.R. Noninvasive diagnosis of intraamniotic infection: proteomic biomarkers in vaginal fluid. Am J Obstet Gynecol 2010, 203:32.e1-32.e8.
15. Hein M., Helmig R.B., Schonheyder H.C., Ganz T., Uldbjerg N. An in vitro study of antibacterial properties of the cervical mucus plug in pregnancy. Am J Obstet Gynecol 2001, 185:586-592.
16. Andersch-Björkman Y., Thomsson K.A., Holmen Larsson J.M., Ekerhovd E., Hansson G.C. Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle. Mol Cell Proteomics 2007, 6:708-716.
17. Panicker G., Lee D.R., Unger E.R. Optimization of SELDI-TOF protein profiling for analysis of cervical mucous. J Proteomics 2009, 71:637-646.
18. Timmons B., Akins M., Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab 2010, 21:353-361.
19. Hassan S., Romero R., Hendler I., Gomez R., Khalek N., Espinoza J., Nien J.K., Berry S.M., Bujold E., Camacho N., Sorokin Y. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med 2006, 34:13-19.
20. Vaisbuch E., Hassan S.S., Mazaki-Tovi S., Nhan-Chang C.L., Kusanovic J.P., Chaiworapongsa T., Dong Z., Yeo L., Mittal P., Yoon B.H., Romero R. Patients with an asymptomatic short cervix (
21. Draghici S., Khatri P., Martins R.P., Ostermeier G.C., Krawetz S.A. Global functional profiling of gene expression. Genomics 2003, 81:98-104.
22. Falcon S., Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics 2007, 23:257-258.
23. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125:279-284.
24. Soni C., Karande A.A. Glycodelin A suppresses the cytolytic activity of CD8+ T lymphocytes. Mol Immunol 2010, 47:2458-2466.
25. Stygar D., Wang H., Vladic Y.S., Ekman G., Eriksson H., Sahlin L. Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod 2002, 67:889-894.
26. Yonemoto H., Young C.B., Ross J.T., Guilbert L.L., Fairclough R.J., Olson D.M. Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor. Placenta 2006, 27:669-677.
27. Dasari S., Pereira L., Reddy A.P., Michaels J.E., Lu X., Jacob T., Thomas A., Rodland M., Roberts C.T., Gravett M.G., Nagalla S.R. Comprehensive proteomic analysis of human cervical-vaginal fluid. J Proteome Res 2007, 6:1259-1268.
28. Klein L.L., Jonscher K.R., Heerwagen M.J., Gibbs R.S., McManaman J.L. Shotgun proteomic analysis of vaginal fluid from women in late pregnancy. Reprod Sci 2008, 15:263-273.
29. Pereira L., Reddy A.P., Jacob T., Thomas A., Schneider K.A., Dasari S., Lapidus J.A., Lu X., Rodland M., Roberts C.T., Gravett M.G., Nagalla S.R. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 2007, 6:1269-1276.
30. Shaw J.L., Smith C.R., Diamandis E.P. Proteomic analysis of human cervico-vaginal fluid. J Proteome Res 2007, 6:2859-2865.
31. Tang L.J., De S.F., Odreman F., Venge P., Piva C., Guaschino S., Garcia R.C. Proteomic analysis of human cervical-vaginal fluids. J Proteome Res 2007, 6:2874-2883.
32. Park S.J., Yoon W.G., Song J.S., Jung H.S., Kim C.J., Oh S.Y., Yoon B.H., Jung G., Kim H.J., Nirasawa T. Proteome analysis of human amnion and amniotic fluid by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proteomics 2006, 6:349-363.
33. Michaels J.E., Dasari S., Pereira L., Reddy A.P., Lapidus J.A., Lu X., Jacob T., Thomas A., Rodland M., Roberts C.T., Gravett M.G., Nagalla S.R. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. J Proteome Res 2007, 6:1277-1285.
34. Michel P.E., Crettaz D., Morier P., Heller M., Gallot D., Tissot J.D., Reymond F., Rossier J.S. Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 2006, 27:1169-1181.
35. Hein M., Petersen A.C., Helmig R.B., Uldbjerg N., Reinholdt J. Immunoglobulin levels and phagocytes in the cervical mucus plug at term of pregnancy. Acta Obstet Gynecol Scand 2005, 84:734-742.
36. Eggert-Kruse W., Botz I., Pohl S., Rohr G., Strowitzki T. Antimicrobial activity of human cervical mucus. Hum Reprod 2000, 15:778-784.
37. Soto E., Espinoza J., Nien J.K., Kusanovic J.P., Erez O., Richani K., Santolaya-Forgas J., Romero R. Human beta-defensin-2: a natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med 2007, 20:15-22.
38. Espinoza J., Chaiworapongsa T., Romero R., Edwin S., Rathnasabapathy C., Gomez R., Bujold E., Camacho N., Kim Y.M., Hassan S., Blackwell S., Whitty J., Berman S., Redman M., Yoon B.H., Sorokin Y. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 2003, 13:2-21.
39. Pacora P., Maymon E., Gervasi M.T., Gomez R., Edwin S.S., Yoon B.H., Romero R. Lactoferrin in intrauterine infection, human parturition, and rupture of fetal membranes. Am J Obstet Gynecol 2000, 183:904-910.
40. Svinarich D.M., Wolf N.A., Gomez R., Gonik B., Romero R. Detection of human defensin 5 in reproductive tissues. Am J Obstet Gynecol 1997, 176:470-475.
41. Tayade C., Esadeg S., Fang Y., Croy B.A. Functions of alpha 2 macroglobulins in pregnancy. Mol Cell Endocrinol 2005, 245:60-66.
42. Skornicka E.L., Kiyatkina N., Weber M.C., Tykocinski M.L., Koo P.H. Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production. Cell Immunol 2004, 232:144-156.
43. Kusanovic J.P., Romero R., Mazaki-Tovi S., Chaiworapongsa T., Mittal P., Gotsch F., Erez O., Vaisbuch E., Edwin S.S., Than N.G., Camacho N., Pacora P., Rogers W., Hassan S.S. Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation. J Matern Fetal Neonatal Med 2008, 21:902-916.
44. Romero R., Kusanovic J.P., Gotsch F., Erez O., Vaisbuch E., Mazaki-Tovi S., Moser A., Tam S., Leszyk J., Master S.R., Juhasz P., Pacora P., Ogge G., Gomez R., Yoon B.H., Yeo L., Hassan S.S., Rogers W.T. Isobaric labeling and tandem mass spectrometry: a novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2010, 23:261-280.
45. Vaisbuch E., Mazaki-Tovi S., Kusanovic J.P., Erez O., Than N.G., Kim S.K., Dong Z., Gotsch F., Mittal P., Chaiworapongsa T., Pacora P., Yeo L., Hassan S.S., Romero R. Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2010, 23:111-119.
46. Bujold E., Romero R., Kusanovic J.P., Erez O., Gotsch F., Chaiworapongsa T., Gomez R., Espinoza J., Vaisbuch E., Mee K.Y., Edwin S., Pisano M., Allen B., Podust V.N., Dalmasso E.A., Rutherford J., Rogers W., Moser A., Yoon B.H., Barder T. Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry. J Matern Fetal Neonatal Med 2008, 21:697-713.
47. Loeffler J., Utermann G., Witsch-Baumgartner M. Molecular prenatal diagnosis of Smith-Lemli-Opitz syndrome is reliable and efficient. Prenat Diagn 2002, 22:827-830.
48. Cunniff C., Kratz L.E., Moser A., Natowicz M.R., Kelley R.I. Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet 1997, 68:263-269.
49. Mills K., Mandel H., Montemagno R., Soothill P., Gershoni-Baruch R., Clayton P.T. First trimester prenatal diagnosis of Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency). Pediatr Res 1996, 39:816-819.
50. Craig W.Y., Haddow J.E., Palomaki G.E., Kelley R.I., Kratz L.E., Shackleton C.H., Marcos J., Stephen T.G., Macrae A.R., Nowaczyk M.J., Kloza E.M., Irons M.B., Roberson M. Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome. Prenat Diagn 2006, 26:842-849.
51. Palomaki G.E., Bradley L.A., Knight G.J., Craig W.Y., Haddow J.E. Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome. J Med Screen 2002, 9:43-44.
52. Anagnostopoulos A.K., Kolialexi A., Mavrou A., Vougas K., Papantoniou N., Antsaklis A., Kanavakis E., Fountoulakis M., Tsangaris G.T. Proteomic analysis of amniotic fluid in pregnancies with Klinefelter syndrome foetuses. J Proteomics 2010, 73:943-950.
53. Wang T.H., Chao A.S., Chen J.K., Chao A., Chang Y.L., Cheng P.J., Chang S.D., Wang H.S. Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes. Fertil Steril 2009, 92:96-107.
54. Grgic O., Matijevic R., Vasilj O. Qualitative glandular cervical score as a potential new sonomorphological parameter in screening for preterm delivery. Ultrasound Med Biol 2006, 32:333-338.
55. Carlstedt I., Lindgren H., Sheehan J.K. The macromolecular structure of human cervical-mucus glycoproteins. Studies on fragments obtained after reduction of disulphide bridges and after subsequent trypsin digestion. Biochem J 1983, 213:427-435.
56. Sheehan J.K., Carlstedt I. The effect of guanidinium chloride on the behaviour of human cervical-mucus glycoproteins. Evidence for unfolding regions of ordered structure in 6M-guanidinium chloride. Biochem J 1984, 221:499-504.